AMBS BOD and BOA are very likely going to surprise
Post# of 30027
1)Lympro partnership or JV
2)Eltoprazine grant and launch of Phase IIb
3 MANF partnership re. RP or any other application
4) MSPrecise CLIA completion and grant, JV or partnership
5) ESS-W and acquisition completion and Gov. grant approval for initiation of Phase III study.....
6) spinoff and IPO for diagnostics division/sale....
I'm sure there are many other possibilities not mentioned, but all of our speculations could be laid to rest with one PR. Patience is going to be substantially rewarded I believe, and soon. Have a restful weekend everyone!